MAPT and Alzheimer disease: Similar to previous studies, our findings showed that AβO infusion induced neuronal loss, as well as increased tau phosphorylation, suggesting that the pathological changes of the hippocampus induced by AβO infusion may be the basis of AD-like behavioral changes [3, 44].